by Oscar Jofre | Oct 3, 2022 | Capital Raising, Compliance, KoreConX, SEC
On September 30, 2022, the SEC announced charges against 8 CEOs and CFOs for fraudulently promoting Regulation A+ securities offerings. The companies named by the SEC include Elegance Brands Inc. (now Sway Energy Corp.), Emerald Health Pharmaceuticals Inc., Hightimes...
by Oscar Jofre | Aug 1, 2022 | Capital Markets, Capital Raising, SEC
For 41 years, the Securities and Exchange Commission has hosted its annual Small Business Forum. The event, led by the SEC’s Office of the Advocate for Small Business Capital Formation, aims to gather feedback from both the public and private sectors to improve...
by Oscar Jofre | Jun 22, 2022 | Capital Raising, KoreConX, SEC
With our KoreSummit on RegA + for Medtech companies quickly approaching, we’d like to introduce the speakers we are thrilled to have for this informative event an exciting and life-changing industry. It is time to meet your MedTech A+ Team. Dawson Russel A...
by Oscar Jofre | Jun 10, 2022 | Capital Raising, SEC
For many issuers outside of the United States, the ability to raise capital from a wide pool of investors, including “the crowd” is immensely compelling. However, for foreign issuers to be able to use RegA+, there are some important considerations to keep in mind....
by Oscar Jofre | Jun 8, 2022 | Capital Markets, SEC
Many investors are turning to the private capital market to make long-term investments in light of the current market conditions. This has increased alternate trading systems and secondary market trading for RegA+, RegCF, and RegD securities. An alternate trading...
by Oscar Jofre | Jun 3, 2022 | Capital Markets, Capital Raising, SEC
In the first half of the year, a great deal has happened in investment crowdfunding. We’ve seen several trends emerge that are worth looking at as we move into 2022. These trends can impact everything from how you raise capital, structure your investments, and...
